Security · CUSIP 29014R301
ELOXX PHARMACEUTICALS INC
COM NEW · institutional ownership from 13F filings
Q3 2026 is still being filed (deadline 45 days after quarter end), so holder counts are incomplete.
13F holders
6
Shares held
420.1K
Value held
$6.4M
New / sold out
1 / 3
Added / reduced
0 / 0
net +19.9K shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q3 2026
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Aberdeen Group plc | 400,000 | $6.1M | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 19,946 | $305.4K | 0.00% |
| Pioneer Family Office, LLC | 96 | $1.5K | 0.00% |
| Towne Trust Company, N.A | 5 | $77 | 0.00% |
| Activest Wealth Management | 4 | $61 | 0.00% |
| SBI Securities Co., Ltd. | 2 | $31 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | New | +19,946 | – |
Biggest sellers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| BARCLAYS PLC | Sold out | -12 | -100.0% |
| CITIGROUP INC | Sold out | -4 | -100.0% |
| Point Nemo Capital, LLC | Sold out | -1 | -100.0% |